MRI Imaging for Research Participants
High-resolution MRI services for sponsored healthcare studies and protocol-based imaging requirements.
Clinical Research Imaging in Texas
River Oaks MRI delivers protocol-based MRI and diagnostic imaging services for CROs, pharmaceutical companies, healthcare organizations, and sponsored research programs with secure reporting and reliable DICOM data delivery.
Research Imaging Services
Research institutions, CROs, pharmaceutical sponsors, and study coordinators can refer participants to River Oaks MRI for quality-focused, protocol-aligned imaging.
High-resolution MRI services for sponsored healthcare studies and protocol-based imaging requirements.
MRI, CT, ultrasound, and fluoroscopy-guided imaging support for research organizations and study coordinators.
Image-guided procedures including liver, renal, and soft-tissue biopsy workflows for research programs.
Interventional Imaging
In addition to advanced MRI and diagnostic imaging services, River Oaks MRI provides image-guided biopsy and interventional imaging support for research participants referred by CROs, healthcare organizations, pharmaceutical companies, and sponsored healthcare programs.
Specialized 3T MRI capabilities for protocol-driven research studies, clinical trial endpoints, and reproducible imaging data.

Recent advancements focus on quantifying liver health non-invasively, reducing the need for biopsies.
A non-invasive “virtual biopsy” that uses acoustic waves to measure liver stiffness and assess fibrosis in NASH/MASH and Cirrhosis patients.
At 3T, FACT provides highly accurate whole-liver fat quantification (Steatosis), offering better reliability than traditional imaging methods.
Advanced 3T contrast imaging helps differentiate benign and malignant liver lesions by evaluating liver cell and bile duct function.
3T MRI is particularly powerful for assessing renal function and oxygenation without using potentially nephrotoxic contrast agents.
BOLD MRI techniques help evaluate tissue oxygenation and ischemic changes.
Detailed analysis of renal tissue microstructure and blood flow for early disease detection.


The high signal strength of 3T is a game-changer for visualizing small vessels and complex flow patterns.
Advanced flow visualization enabling assessment of turbulence, wall shear stress, and vascular abnormalities.
High-resolution vessel imaging without gadolinium for patients with impaired kidney function.
Detection of vulnerable plaques, vasculitis, and vessel wall pathology.
| Feature | Clinical Benefit |
|---|---|
| Increased SNR | Enables thinner slices and improved detection of small lesions and distal vessels. |
| Parallel Imaging | Reduces breath-hold time significantly for liver and kidney studies in elderly patients.. |
| Spectroscopy | Better separation of metabolites, allowing for advanced biochemical analysis of tissue. |
Clinical Research Trials
Advanced MRI and diagnostic imaging for clinical research studies and protocol-based requirements—with secure reporting for CROs and study coordinators.
Why Choose Us

High-resolution MRI services for research participants, sponsored healthcare studies, and protocol-based imaging requirements.

MRI, CT, ultrasound, and fluoroscopy-guided imaging support for research organizations and study coordinators.

Accurate imaging processes designed to support study-specific MRI and diagnostic imaging requirements.

Dedicated imaging professionals focused on consistency, accuracy, and reliable diagnostic reporting.

Efficient reporting workflows and secure imaging data delivery for CROs, research institutions, and sponsored healthcare programs.
Regulatory & Data Governance
Protocol-driven imaging is only as reliable as the systems behind it. River Oaks MRI aligns research workflows with FDA, HIPAA, and sponsor audit expectations at every step of the imaging lifecycle.
Our secure electronic systems, data workflows, and image transfers strictly adhere to FDA criteria for electronic records and electronic signatures—supporting audit-ready research documentation from acquisition through core lab delivery.
We enforce rigorous HIPAA compliance by completely stripping Protected Health Information (PHI) from DICOM metadata headers at the source, before any secure transfer to sponsors, CROs, or core imaging laboratories.
Our facility operates under rigorous Standard Operating Procedures (SOPs) governing routine phantom scanning, machine calibration, and swift query resolution—helping ensure zero data drift across long-term longitudinal studies.
CROs, pharmaceutical sponsors, and study coordinators share imaging protocols and reporting expectations.
Participants are scheduled quickly and scanned with protocol-aligned MRI and diagnostic imaging workflows.
Reports and imaging data are delivered through secure channels with reliable turnaround.
Yes. River Oaks MRI works with CROs, pharmaceutical companies, healthcare organizations, and study coordinators for participant imaging services.
Yes. We provide protocol-based MRI and diagnostic imaging services for participants involved in clinical studies and sponsored programs.
River Oaks MRI offers MRI, CT, ultrasound, fluoroscopy-guided imaging, and image-guided interventional procedures for research studies.
Absolutely. Our imaging specialists follow protocol-specific imaging requirements and reporting standards accurately.
Research organizations choose us for advanced 3T MRI technology, fast scheduling, secure reporting, and reliable imaging services.
Yes. We provide secure DICOM image transfer, fast reporting, and efficient imaging data delivery for research organizations.
Yes. Our advanced 3T MRI system delivers high-resolution imaging and reliable performance for protocol-based imaging studies.
Yes. Our team provides fast and coordinated scheduling for timely MRI and diagnostic imaging appointments.
Yes. River Oaks MRI supports longitudinal and repeat imaging requirements for ongoing sponsored healthcare studies.
River Oaks MRI combines advanced imaging technology, experienced radiologists, secure reporting, and protocol-based imaging workflows.
Research Intake Center
Pharmaceutical sponsors, CROs, and study coordinators can initiate protocol feasibility, site capability review, or de-identified participant referrals through our secure research intake workflow.